Latham & Watkins announced that Melanie Howard has joined the firm’s London office as a partner in the Corporate Department and member of the Healthcare & Life Sciences and Fintech Industry Groups. Howard advises companies, private equity firms, and investment banks on a variety of complex domestic and cross-border transactions, such as M&A, strategic alliances, joint ventures, and disposals.
Howard has a wealth of experience across a number of healthcare and life sciences subsectors, such as the healthcare and life sciences supply chain, pharmaceuticals, and biotechnology. And she also advises on transactions in the financial services and fintech industries, and regularly counsels clients on takeover code issues, securities law, listing rules, and corporate and acquisition financing structures.
Howard joins Latham & Watkins from Baker McKenzie. And she earned her BA from the University of Tasmania and is admitted to practice as a Registered Foreign Lawyer in England & Wales and Victoria, Australia.
KEY QUOTES:
“As an experienced M&A lawyer with deep industry expertise, Melanie’s arrival further reinforces our European and global stature as one of the preeminent M&A firms with deep expertise in the healthcare and life sciences and other regulated sectors. She brings first-class experience advising leading healthcare and life sciences companies, financial institutions, and investors on a variety of innovative transactions, and her market standing will be of tremendous value to our clients.”
- Stephen Kensell, Office Managing Partner of Latham & Watkins in London
“Melanie is an accomplished and business-savvy dealmaker, with extensive experience advising on big ticket deals which are a hallmark of our global practice. The healthcare and life sciences industry is a key driver of global M&A activity and represents a key pillar of the firm’s global strategy. We continue to see an increasing sophistication and complexity of deals in the sector, and are delighted to be adding a partner of Melanie’s stature, knowledge, and proven track record in the sector to the practice.”
- Sam Newhouse, Global Vice Chair of Latham’s M&A Practice
“Latham has a unique ability to advise clients across the full spectrum of healthcare and life sciences transactions, commercial and regulatory issues, and groundbreaking disputes. Melanie’s expertise strongly complements the firm’s global capabilities, and we are excited to welcome her to the firm.”
- Robbie McLaren, Global Vice Chair of Latham’s Healthcare & Life Sciences Industry Group
